drugset / Trial / NCT01806051

A Pilot Study on Diurnal Variation

NCT01806051

Non-randomizedParallel-groupOpen-label

Summary

This self-controlled, prospective, pilot study is designed to gather information regarding the diurnal variation (changes that occur each day) in the levels of plasma phenylalanine (Phe) and tyrosine in patients with phenylketonuria (PKU) and in the non-PKU population.

Timeline

Start
2013-03
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject sapropterin Unknown 20 mg/kg

Indications